Indegene Past Earnings Performance

Past criteria checks 5/6

Indegene has been growing earnings at an average annual rate of 25.3%, while the Life Sciences industry saw earnings growing at 25.2% annually. Revenues have been growing at an average rate of 9.7% per year. Indegene's return on equity is 15.8%, and it has net margins of 13.8%.

Key information

25.3%

Earnings growth rate

23.4%

EPS growth rate

Life Sciences Industry Growth11.2%
Revenue growth rate9.7%
Return on equity15.8%
Net Margin13.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Indegene makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BSE:544172 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2427,0973,73017,3220
30 Jun 2426,5863,56016,9120
31 Mar 2425,8963,36716,5600
31 Dec 2325,4892,90716,4520
30 Jun 2323,9272,48715,5930
31 Mar 2323,0612,66114,6880
31 Mar 2216,6461,64810,2220
31 Mar 219,8061,8575,4030
31 Mar 206,4365583,7380

Quality Earnings: 544172 has high quality earnings.

Growing Profit Margin: 544172's current net profit margins (13.8%) are higher than last year (10.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 544172's earnings have grown significantly by 25.3% per year over the past 5 years.

Accelerating Growth: 544172's earnings growth over the past year (38.3%) exceeds its 5-year average (25.3% per year).

Earnings vs Industry: 544172 earnings growth over the past year (38.3%) exceeded the Life Sciences industry 37.9%.


Return on Equity

High ROE: 544172's Return on Equity (15.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies